Abstract:The presence of pre-existing or acquired drug-resistant cells within the tumor often leads to tumor relapse and metastasis. Single-cell RNA sequencing (scRNA-seq) enables elucidation of the subtle differences in drug responsiveness among distinct cell subpopulations within tumors. A few methods have employed scRNA-seq data to predict the drug response of individual cells to date, but their performance is far from satisfactory. In this study, we propose SSDA4Drug, a semi-supervised few-shot transfer learning method for inferring drug-resistant cancer cells. SSDA4Drug extracts pharmacogenomic features from both bulk and single-cell transcriptomic data using semi-supervised adversarial domain adaptation. This allows us to transfer knowledge of drug sensitivity from bulk-level cell lines to single cells. We conduct extensive performance evaluation experiments across multiple independent scRNA-seq datasets, demonstrating SSDA4Drug’s superior performance over current state-of-the-art methods. Remarkably, with only one or two labeled target-domain samples, SSDA4Drug significantly boosts the predictive performance of single-cell drug responses. Moreover, SSDA4Drug accurately recapitulates the temporally dynamic changes of drug responses during continuous drug exposure of tumor cells, and successfully identifies reversible drug-responsive states in lung cancer cells, which initially acquire resistance through drug exposure but later restore sensitivity during drug holidays. Also, our predicted drug responses consistently align with the developmental patterns of drug sensitivity observed along the evolutionary trajectory of oral squamous cell carcinoma cells. In addition, our derived SHAP values and integrated gradients effectively pinpoint the key genes involved in drug resistance in prostate cancer cells. These findings highlight the exceptional performance of our method in determining single-cell drug responses. This powerful tool holds the potential for identifying drug-resistant tumor cell subpopulations, paving the way for advancements in precision medicine and novel drug development.

SuperFeat: Quantitative Features Learning from Single-cell RNAseq Data Facilitates Drug Repurposing

SuperFeat: Quantitative Feature Learning from Single-cell RNA-seq Data Facilitates Drug Repurposing

Quantitative Learning of Cellular Features From Single-cell Transcriptomics Data Facilitates Effective Drug Repurposing

Scrank Infers Drug-Responsive Cell Types from Untreated Scrna-Seq Data Using a Target-Perturbed Gene Regulatory Network

DrugReSC: targeting disease-critical cell subpopulations with single-cell transcriptomic data for drug repurposing in cancer

Enabling Single‐Cell Drug Response Annotations from Bulk RNA‐Seq Using SCAD

DrugRepo: a novel approach to repurposing drugs based on chemical and genomic features

Prudent Application of Single-Cell RNA Sequencing in Understanding Cellular Features and Functional Phenotypes in Cancer Studies

DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration

A Systematic Approach to Featurization for Cancer Drug Sensitivity Predictions with Deep Learning

RNA sequencing identifies lung cancer lineage and facilitates drug repositioning

A Genome-Wide Positioning Systems Network Algorithm for in Silico Drug Repurposing

A New Approach to Drug Repurposing with Two-Stage Prediction, Machine Learning, and Unsupervised Clustering of Gene Expression

Deep Transfer Learning of Drug Responses by Integrating Bulk and Single-cell RNA-seq data

Applications of single-cell RNA sequencing in drug discovery and development

scPharm: identifying pharmacological subpopulations of single cells for precision medicine in cancers

DrugSim2DR: systematic prediction of drug functional similarities in the context of specific disease for drug repurposing

TransCell: In silico Characterization of Genomic Landscape and Cellular Responses by Deep Transfer Learning

Identifying drug-resistant individual cells within tumors by semi-supervised transfer learning from bulk to single-cell transcriptome

scDrug+: predicting drug-responses using single-cell transcriptomics and molecular structure

Trends and Potential of Machine Learning and Deep Learning in Drug Study at Single-Cell Level